Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
17,350,000
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1,056,670
-
Shares change
-
+104,282
-
Total reported value, excl. options
-
$861,151
-
Value change
-
+$57,582
-
Number of buys
-
10
-
Number of sells
-
-9
-
Price
-
$0.8150
Significant Holders of PAVmed Inc. - Common (PAVM) as of Q2 2024
26 filings reported holding PAVM - PAVmed Inc. - Common as of Q2 2024.
PAVmed Inc. - Common (PAVM) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,056,670 shares
of 17,350,000 outstanding shares and own 6.1% of the company stock.
Largest 10 shareholders include FIRST MANHATTAN CO. LLC. (500,000 shares), VANGUARD GROUP INC (295,390 shares), BlackRock Inc. (74,912 shares), GEODE CAPITAL MANAGEMENT, LLC (73,634 shares), TWO SIGMA SECURITIES, LLC (25,225 shares), STATE STREET CORP (20,854 shares), Virtu Financial LLC (15,099 shares), NORTHERN TRUST CORP (11,706 shares), XML Financial, LLC (10,067 shares), and Tower Research Capital LLC (TRC) (9,704 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.